House Appropriations Committee Embraces Clinical Trial Issues In FY 2022 US FDA Budget Bill

 
• By Derrick Gingery

Report language includes several mentions of improving trial diversity and recruitment, while bill offers a 5% increase in funding.

Capitol dollars in the sky (Alamy)
The FDA would receive nearly $300m more in FY 2022 compared to the previous year in legislation approved by the House Appropriations Committee. • Source: Alamy

More from Legislation

More from Pink Sheet